Giant Cell Arteritis (GCA)Symptoms, Doctors, Treatments, Advances & More
Learn About Giant Cell Arteritis (GCA)
- Giant cell arteritis
- Arteritis cranialis
- Arteritis temporalis
- Cranial arteritis
- GCA
- Horton's arteritis
- Horton's giant cell arteritis
- Horton's temporal arteritis
- Horton’s disease
- Horton’s syndrome
- Temporal arteritis
Johns Hopkins Bayview Medical Center
Dr. Philip Seo is an Associate Professor in the Division of Rheumatology. A graduate of Harvard College and the College of Physicians and Surgeons at Columbia University, Dr. Seo completed his Internal Medicine training as a member of the Osler Medical Service at the Johns Hopkins Hospital. Since then, he has worked at Johns Hopkins in several capacities, including as a hospitalist at Johns Hopkins Bayview Medical Center, and as an Assistant Chief of Service of the Department of Medicine at the Johns Hopkins Hospital, before joining the Division of Rheumatology. Dr. Seo is the Director of the Johns Hopkins Vasculitis Center and Director of the Johns Hopkins Rheumatology Fellowship Program. His clinical interests lie in the assessment and treatment of patients with systemic vasculitis, in particular, the ANCA-associated vasculitides, which include granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis. Dr. Seo is rated as an Elite provider by MediFind in the treatment of Giant Cell Arteritis (GCA). His top areas of expertise are Granulomatosis with Polyangiitis, Vasculitis, Microscopic Polyangiitis, Takayasu Arteritis, and Tissue Biopsy.
Tanaz Kermani is a Rheumatologist in Santa Monica, California. Dr. Kermani is rated as an Elite provider by MediFind in the treatment of Giant Cell Arteritis (GCA). Her top areas of expertise are Temporal Arteritis, Giant Cell Arteritis (GCA), Vasculitis, and Takayasu Arteritis. Dr. Kermani is currently accepting new patients.
Perelman Center For Advanced Medicine
Peter Merkel is a Rheumatologist in Philadelphia, Pennsylvania. Dr. Merkel is rated as an Elite provider by MediFind in the treatment of Giant Cell Arteritis (GCA). His top areas of expertise are Granulomatosis with Polyangiitis, Vasculitis, Microscopic Polyangiitis, Takayasu Arteritis, and Tissue Biopsy. Dr. Merkel is currently accepting new patients.
Summary: This is a multi-center, randomized, open label study that will assess the efficacy and safety of ACTEMRA(R) or one of its FDA-approved biosimilars Tocilizumab (TCZ) maintenance versus withdrawal in Giant cell arteritis (GCA) patients who are in remission after at least 12 months of high dose TCZ treatment. Eligible participants will also have discontinued glucocorticoids (e.g., prednisone (or equi...
Summary: This randomized, double-blind, placebo-controlled trial will seek to determine the efficacy of abatacept in GCA. To examine this objective, 62 eligible patients who have newly diagnosed or relapsing GCA within 8 weeks prior to screening will be randomized at a 1:1 ratio to receive subcutaneous abatacept 125mg/week or placebo. Patients who achieve remission will remain on their blinded assignment f...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center